ENGNW

ENGNW represents warrants issued by enGene Holdings Inc., a clinical-stage biotechnology company. These derivative securities give holders the right to purchase ENGN common stock at a predetermined price within a specified time period. Warrants typically have longer expiration periods than standard options and may be exercised when the underlying stock price exceeds the strike price. Trading volume and liquidity for warrants are generally lower than the underlying common shares.